A new article published in BIO Integration on Apr. 2 highlights the use of ultrasound technology for real-time monitoring and treatment of tumor vasculature. The publication outlines how abnormal blood vessel growth within tumors contributes to their progression by creating hypoxic and acidic environments, which can make them resistant to therapy.
This topic is significant because targeting the blood vessels that supply tumors has become an important strategy in cancer treatment. Traditional methods such as anti-angiogenic drugs, vascular disrupting agents, and embolization have shown effectiveness but are often limited by their focus on a single target, making it difficult to address the complexity and changing needs of different tumor stages.
The article explains that rapid disruption of blood vessels is useful for shrinking advanced tumors, while normalizing these vessels can improve outcomes when combined with chemotherapy or radiotherapy at earlier stages. Ultrasound stands out because it can be adjusted to achieve various effects—such as suppressing new vessel formation, disrupting existing vessels, or dilating them—depending on what is needed at each stage of treatment.
Unlike traditional static imaging techniques, ultrasound provides dynamic visualization of angiogenesis and allows clinicians to evaluate how well treatments are working in real time. This capability helps guide intervention strategies more precisely and could lead to better optimization of cancer therapies.
The review also discusses recent advances in using ultrasound for both targeting tumor vasculature and monitoring its response during therapy. It addresses challenges related to bringing these technologies into clinical practice and explores future directions for research. The authors suggest that integrating ultrasound-driven approaches could pave the way for more personalized cancer treatments that adapt over time.
